Press Release June 21, 2022

June 21, 2022 by Barbara Dunford

Comments are closed.

\nCAPSTONE HOLDING CORP. ANNOUNCES EXERCISE OF SECURED DEBT AND INTEREST CONVERSION OPTION BY MAJORITY SHAREHOL...

\nCAPSTONE THERAPEUTICS CORP. ANNOUNCES RESULTS OF ANNUAL MEETING\n...

\nThe Annual Meeting of Stockholders of Capstone Therapeutics Corp. will be held on Thursday, December 1, 2021\n...

\nCAPSTONE THERAPEUTICS CORP. ANNOUNCES TRANSACTION WITH DIAMOND PRODUCTS HOLDINGS, LLC\n...

\nCAPSTONE THERAPEUTICS ANNOUNCES OPERATING RESULTS FOR FISCAL 2020 – INCLUDING A CHANGE IN ITS DEFERRED TAX ...

\nCAPSTONE THERAPEUTICS ANNOUNCES RESULTS OF SPECIAL SHAREHOLDER MEETING, AND A LICENSE TRANSFER/ROYALTY AGREEM...

\nCapstone Therapeutics Announces Exercise of Secured Debt and Interest Conversion Option by BP Peptides, LLC a...

\nCapstone Therapeutics Annouces Transaction With TotalStone LLC\n...

LipimetiX Development Announces Sub-License of APO E Mimetic Peptide Platform to Anji Pharma, China...

CAPSTONE THERAPEUTICS ANNOUNCES TRANSACTION FOR SALE OF SHARES OF ITS COMMON STOCK and SECURED LOAN...

Top